E
Eric Vivier
Researcher at Aix-Marseille University
Publications - 476
Citations - 51804
Eric Vivier is an academic researcher from Aix-Marseille University. The author has contributed to research in topics: Interleukin 21 & Natural killer cell. The author has an hindex of 110, co-authored 452 publications receiving 44199 citations. Previous affiliations of Eric Vivier include Harvard University & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
How to extinguish lymphocyte activation, immunotyrosine-based inhibition motif (ITIM)-bearing molecules a solution?
Mathieu Blery,Eric Vivier +1 more
TL;DR: ITIM-bearing molecules represent a novel family of inhibitory receptors expressed widely through the hematopoietic compartment and are able to recruit phosphatases on their phosphorylated ITIM and thus mediate a localized inhibition of the transduction pathways.
Journal ArticleDOI
A point mutation in the Ncr1 signal peptide impairs the development of innate lymphoid cell subsets.
Francisca F. Almeida,Francisca F. Almeida,Sara Tognarelli,Sara Tognarelli,Antoine Marçais,Andrew J. Kueh,Andrew J. Kueh,Miriam E. Friede,Yang Liao,Yang Liao,Simon N. Willis,Simon N. Willis,Kylie Luong,Kylie Luong,Fabrice Faure,Francois Mercier,Justine Galluso,Matthew A. Firth,Matthew A. Firth,Emilie Narni-Mancinelli,Bushra Rais,Bushra Rais,David T. Scadden,Francesco Spallotta,Sandra Weil,Sandra Weil,Ariane Giannattasio,Ariane Giannattasio,Franziska Kalensee,Franziska Kalensee,Tobias Zöller,Nicholas D. Huntington,Nicholas D. Huntington,Ulrike Schleicher,Andreas G. Chiocchetti,Sophie Ugolini,Marco J Herold,Marco J Herold,Wei Shi,Wei Shi,Joachim Koch,Joachim Koch,Alexander Steinle,Eric Vivier,Thierry Walzer,Gabrielle T. Belz,Gabrielle T. Belz,Evelyn Ullrich +47 more
TL;DR: A spontaneous point mutation in the signal peptide of the NKp46 protein in congenic Ly5.1 mice reveals thatNKp46 is important for NK cell and ILC differentiation, maturation and function.
Journal ArticleDOI
Phase I Trial of Prophylactic Donor-Derived IL-2-Activated NK Cell Infusion after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Sibling Donor.
Raynier Devillier,Boris Calmels,Sophie Guia,Mohammed Taha,Cyril Fauriat,Bechara Mfarrej,Geoffroy Venton,Eric Vivier,Daniel Olive,Christian Chabannon,Didier Blaise,Sophie Ugolini +11 more
TL;DR: In this article, a phase-I clinical trial evaluating the safety of a prophylactic donor-derived ex vivo IL-2 activated NK cell (IL-2 NK) infusion after allo-HSCT for patients with hematologic malignancies was designed.
Journal ArticleDOI
Publisher Correction: Harnessing innate immunity in cancer therapy.
Olivier Demaria,Stéphanie Cornen,Marc Daëron,Marc Daëron,Yannis Morel,Ruslan Medzhitov,Eric Vivier +6 more
TL;DR: An Amendment to this paper has been published and can be accessed via a link at the top of the paper.
Journal ArticleDOI
The Abl-1 Kinase is Dispensable for NK Cell Inhibitory Signalling and is not Involved in Murine NK Cell Education.
Sridharan Ganesan,Thuy T. Luu,Benedict J. Chambers,Stephan Meinke,Petter Brodin,Eric Vivier,Dawn M. Wetzel,Anthony J. Koleske,Nadir Kadri,Petter Höglund +9 more
TL;DR: C‐Abl deficiency in NK cells did not affect NK cell inhibition via the receptors Ly49G2, Ly49A and NKG2A and it is concluded that signalling downstream of murine inhibitory receptors does not involve c-Abl and that c‐ABL plays no major role in NK cell education in the mouse.